Endothelin 1
Template:Infobox gene Endothelin 1 (ET-1), also known as preproendothelin-1 (PPET1), is a potent vasoconstrictor peptide produced by vascular endothelial cells,[1] as well as by cells in the heart (affecting contractility) and kidney (affecting sodium handling).[2] The protein encoded by this gene Template:Ndash EDN1 Template:Ndash is proteolytically processed to release endothelin 1. Endothelin 1 is one of three isoforms of human endothelin.
Sources
Preproendothelin is precursor of the peptide ET-1. Endothelial cells convert preproendothelin to proendothelin and subsequently to mature endothelin, which the cells release.[1][3]
Clinical significance
Patients with salt-sensitive hypertension have higher plasma ET-1.[2] Endothelin-1 receptor antagonists (Bosentan) are used in the treatment of pulmonary hypertension.[1] Use of these antagonists prevents pulmonary arterial constriction and thus inhibits pulmonary hypertension.[1]
As of 2020, the role of endothelin-1 in affecting lipid metabolism and insulin resistance in obesity mechanisms was under clinical research.[4]
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain.